ASAH Antibodies

Santa Cruz Biotechnology supplies a comprehensive collection of ASAH Antibodies for research focused on understanding acid sphingomyelinase (ASAH) in various biological processes. ASAH Antibodies are validated for multiple techniques, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Acid sphingomyelinase plays a crucial role in the metabolism of sphingolipids, which are essential components of cell membranes and participate in cell signaling, apoptosis, and inflammation. ASAH dysregulation has been linked to several diseases, including neurodegenerative disorders and cancer, highlighting its importance as a therapeutic target. Research into ASAH function continues to reveal new insights about cellular processes and disease mechanisms. Investigating acid sphingomyelinase activity helps advance understanding of lipid metabolism and its impact on cellular health. Studying ASAH expression patterns can illuminate its role in disease progression and potential treatment strategies. Exploring the relationship between ASAH and cellular stress responses provides valuable information about disease development. Santa Cruz Biotechnology monoclonal antibodies support researchers worldwide in advancing scientific knowledge about acid sphingomyelinase and its significance in human health and disease.